DK0839196T3 - Humant CTLA-8 og anvendelser af CTLA-8-relaterede proteiner - Google Patents

Humant CTLA-8 og anvendelser af CTLA-8-relaterede proteiner

Info

Publication number: DK0839196T3
Authority: DK; Denmark
Prior art keywords: ctla; acid sequence; amino acid; seq; related proteins
Prior art date: 1995-07-19

Application number

DK96927237T

Other languages

English (en)

Inventor

Kenneth Jacobs

Samuel Goldman

Kerry Kelleher

Mckeough Carlin

Debra Pittman

Sha Mi

Steven Neben

Joann Giannotti

Margaret Golden-Fleet

Original Assignee

Inst Genetics Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-07-19

Filing date

1996-07-18

Publication date

2005-09-12

1995-08-11 Priority claimed from US08/514,014 external-priority patent/US5707829A/en

1996-07-18 Application filed by Inst Genetics Llc filed Critical Inst Genetics Llc

2005-09-12 Application granted granted Critical

2005-09-12 Publication of DK0839196T3 publication Critical patent/DK0839196T3/da

Links

108050003558 Interleukin-17 Proteins 0.000 title abstract 2
102000013691 Interleukin-17 Human genes 0.000 title abstract 2
102000004169 proteins and genes Human genes 0.000 title abstract 2
108090000623 proteins and genes Proteins 0.000 title abstract 2
101000998146 Homo sapiens Interleukin-17A Proteins 0.000 title 1
125000003275 alpha amino acid group Chemical group 0.000 abstract 6
150000001413 amino acids Chemical class 0.000 abstract 3
108090001005 Interleukin-6 Proteins 0.000 abstract 1
108090001007 Interleukin-8 Proteins 0.000 abstract 1
239000012634 fragment Substances 0.000 abstract 1
230000006698 induction Effects 0.000 abstract 1
230000014399 negative regulation of angiogenesis Effects 0.000 abstract 1
230000028327 secretion Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Diabetes (AREA)
Virology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
Pulmonology (AREA)
Hematology (AREA)
Physical Education & Sports Medicine (AREA)
Neurology (AREA)
Gastroenterology & Hepatology (AREA)
Endocrinology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Biomedical Technology (AREA)
Transplantation (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
AIDS & HIV (AREA)
Cardiology (AREA)
Obesity (AREA)
Heart & Thoracic Surgery (AREA)

DK96927237T 1995-07-19 1996-07-18 Humant CTLA-8 og anvendelser af CTLA-8-relaterede proteiner DK0839196T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US50403295A	1995-07-19	1995-07-19
US08/514,014 US5707829A (en)	1995-08-11	1995-08-11	DNA sequences and secreted proteins encoded thereby
PCT/US1996/011889 WO1997004097A2 (en)	1995-07-19	1996-07-18	Human ctla-8 and uses of ctla-8-related proteins

Publications (1)

Publication Number	Publication Date
DK0839196T3 true DK0839196T3 (da)	2005-09-12

Family

ID=27054704

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK96927237T DK0839196T3 (da)	1995-07-19	1996-07-18	Humant CTLA-8 og anvendelser af CTLA-8-relaterede proteiner

Country Status (10)

Country	Link
EP (2)	EP0839196B1 (da)
JP (3)	JPH11510045A (da)
AT (1)	ATE295414T1 (da)
AU (1)	AU727480B2 (da)
CA (1)	CA2227220A1 (da)
DE (1)	DE69634726T2 (da)
DK (1)	DK0839196T3 (da)
ES (1)	ES2242966T3 (da)
PT (1)	PT839196E (da)
WO (1)	WO1997004097A2 (da)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6274711B1 (en)	1993-06-14	2001-08-14	Inserm, Institut National De La Sante Et De La Recherche Medicale	Purified mammalian CTLA-8 antigens and related reagents
US5707829A (en) *	1995-08-11	1998-01-13	Genetics Institute, Inc.	DNA sequences and secreted proteins encoded thereby
WO1999043693A1 (en) *	1998-02-26	1999-09-02	Human Genome Sciences, Inc.	36 human secreted proteins
US7053190B2 (en)	1997-03-07	2006-05-30	Human Genome Sciences, Inc.	Secreted protein HRGDF73
EP1352962A1 (en) *	1997-03-07	2003-10-15	Human Genome Sciences, Inc.	186 human secreted proteins
US6420526B1 (en)	1997-03-07	2002-07-16	Human Genome Sciences, Inc.	186 human secreted proteins
WO1998042738A1 (en) *	1997-03-21	1998-10-01	Human Genome Sciences, Inc.	87 human secreted proteins
CA2284131A1 (en)	1997-03-07	1998-09-11	Human Genome Sciences, Inc.	70 human secreted proteins
US6878687B1 (en)	1997-03-07	2005-04-12	Human Genome Sciences, Inc.	Protein HMAAD57
WO1998039448A2 (en) *	1997-03-07	1998-09-11	Human Genome Sciences, Inc.	186 human secreted proteins
JP2001519667A (ja) *	1997-04-10	2001-10-23	ジェネティックス・インスチチュート・インコーポレーテッド	分泌発現配列タグ（ｓＥＳＴｓ）
WO1998045437A2 (en) *	1997-04-10	1998-10-15	Genetics Institute, Inc.	SECRETED EXPRESSED SEQUENCE TAGS (sESTs)
JP2001519666A (ja) *	1997-04-10	2001-10-23	ジェネティックス・インスチチュート・インコーポレーテッド	分泌発現配列タグ（ｓＥＳＴｓ）
CA2291260A1 (en) *	1997-06-06	1998-12-10	Human Genome Sciences, Inc.	207 human secreted proteins
EP1428833A3 (en) *	1997-06-06	2004-07-07	Human Genome Sciences, Inc.	207 human secreted proteins
US6548633B1 (en)	1998-12-22	2003-04-15	Genset, S.A.	Complementary DNA's encoding proteins with signal peptides
US6562578B1 (en)	1999-01-11	2003-05-13	Schering Corporation	IL-17-like cytokine binding compounds and antibodies
US7060479B2 (en)	1999-12-08	2006-06-13	Serono Genetics Institute, S.A.	Full-length human cDNAs encoding potentially secreted proteins
US7223727B2 (en)	1998-04-09	2007-05-29	Serono Genetics Institute S.A.	GSSP4 polynucleotides and polypeptides and uses thereof
US6251583B1 (en)	1998-04-27	2001-06-26	Schering Corporation	Peptide substrates for HCV NS3 protease assays
US7771719B1 (en)	2000-01-11	2010-08-10	Genentech, Inc.	Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
PT1076703E (pt)	1998-05-15	2007-10-10	Genentech Inc	''utilizações terapêuticas de polipéptido homólogos de il-17''
CA2329274A1 (en) *	1998-05-29	1999-12-02	Steven M. Ruben	Interleukin-21
JP2002518010A (ja) *	1998-06-16	2002-06-25	ヒューマンジノームサイエンシーズ，インコーポレイテッド	９４個のヒト分泌タンパク質
JP2002520050A (ja) *	1998-07-15	2002-07-09	ヒューマンジノームサイエンシーズ，インコーポレイテッド	７１個のヒト分泌タンパク質
US7091315B1 (en)	1998-07-15	2006-08-15	Human Genome Sciences, Inc.	Protein HDPBQ71
JP2002525056A (ja) *	1998-09-17	2002-08-13	ザイモジェネティクス，インコーポレイティド	哺乳類のトランスフォーミング増殖因子β−９
KR20010089764A (ko) *	1999-01-11	2001-10-08	둘락 노먼 씨.	인터류킨-17과 관련된 포유류의 사이토카인, 이를코딩하는 폴리뉴클레오티드 및 이의 용도
CA2296792A1 (en) *	1999-02-26	2000-08-26	Genset S.A.	Expressed sequence tags and encoded human proteins
EP1053751A1 (en) *	1999-05-17	2000-11-22	Institut National De La Sante Et De La Recherche Medicale (Inserm)	Compositions and methods for treating cell proliferation disorders
CA2387959A1 (en) *	1999-11-12	2001-05-17	Human Genome Sciences, Inc.	21 human secreted proteins
WO2001042451A2 (en)	1999-12-08	2001-06-14	Genset	FULL-LENGTH HUMAN cDNAs ENCODING POTENTIALLY SECRETED PROTEINS
CA2401716A1 (en) *	2000-02-29	2001-09-07	Zymogenetics, Inc.	Methods for promoting production of myelin by schwann cells
US7718397B2 (en)	2000-03-21	2010-05-18	Genentech, Inc.	Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
EP2020239A1 (en) *	2000-04-18	2009-02-04	Schering Corporation	Use of IL-174 agonists for treating infectious diseases
US20030096969A1 (en)	2000-06-02	2003-05-22	Genentech, Inc.	Secreted and transmembrane polypeptides and nucleic acids encoding the same
CN1329090A (zh) *	2000-06-21	2002-01-02	上海博德基因开发有限公司	一种新的多肽——人自身免疫疾病相关蛋白10和编码这种多肽的多核苷酸
MXPA03003407A (es) *	2000-10-18	2004-05-04	Immunex Corp	Metodos para el tratamiento de artritis reumatoide usando antagonistas il-17.
CA2842429A1 (en) *	2001-10-19	2003-05-01	Genentech, Inc.	Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
US20070048301A1 (en) *	2002-11-26	2007-03-01	Bodary-Winter Sarah C	Compositions and methods for the treatment of immune related diseases
PL2784084T3 (pl) *	2003-07-08	2020-03-31	Genentech, Inc.	Przeciwciała antagonistyczne wobec heterologicznych polipeptydów IL-17A/F
JP4833850B2 (ja)	2003-11-21	2011-12-07	ユセベファルマソシエテアノニム	Ｉｌ−１７活性阻害による多発性硬化症を治療するための方法
GB0417487D0 (en)	2004-08-05	2004-09-08	Novartis Ag	Organic compound
CA2646478A1 (en)	2006-03-10	2007-09-20	Zymogenetics, Inc.	Antibodies that bind both il-17a and il-17f and methods of using the same
US7790163B2 (en)	2006-03-10	2010-09-07	Zymogenetics, Inc.	Antibodies that bind both IL-17A and IL-17F and methods of using the same
US7767206B2 (en)	2006-10-02	2010-08-03	Amgen Inc.	Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto
EP2150564A2 (en)	2007-04-27	2010-02-10	ZymoGenetics, Inc.	Antagonists to il-17a, il-17f, and il-23p19 and methods of use
CA2721713C (en)	2008-05-05	2019-07-09	Novimmune Sa	Anti-il-17a/il-17f cross-reactive antibodies and methods of use thereof
MX348013B (es)	2009-05-05	2017-05-23	Novimmune Sa	Anticuerpos anti il-17f y metodos de uso de los mismos.
WO2010133662A1 (en) *	2009-05-20	2010-11-25	INSERM (Institut National de la Santé et de la Recherche Médicale)	Use of il-17 polypeptides for use in the prevention or treatment of atherosclerosis
WO2011088120A1 (en)	2010-01-15	2011-07-21	Amgen Inc.	Antibody formulation and therapeutic regimens
ME02734B (me)	2011-01-14	2017-10-20	Ucb Biopharma Sprl	Antitelo koje vezuje il-17a i il-17f
UA117218C2 (uk)	2011-05-05	2018-07-10	Мерк Патент Гмбх	Поліпептид, спрямований проти il-17a, il-17f та/або il17-a/f

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6562333B1 (en) *	1993-06-14	2003-05-13	Schering Corporation	Purified mammalian CTLA-8 antigens and related reagents
DK0817847T4 (da) *	1995-03-23	2009-10-05	Immunex Corp	IL-17-receptor
US5707829A (en) *	1995-08-11	1998-01-13	Genetics Institute, Inc.	DNA sequences and secreted proteins encoded thereby

1996
- 1996-07-18 WO PCT/US1996/011889 patent/WO1997004097A2/en active IP Right Grant
- 1996-07-18 CA CA002227220A patent/CA2227220A1/en not_active Abandoned
- 1996-07-18 JP JP9506846A patent/JPH11510045A/ja not_active Withdrawn
- 1996-07-18 EP EP96927237A patent/EP0839196B1/en not_active Expired - Lifetime
- 1996-07-18 EP EP05009086A patent/EP1591529A3/en not_active Withdrawn
- 1996-07-18 AT AT96927237T patent/ATE295414T1/de not_active IP Right Cessation
- 1996-07-18 PT PT96927237T patent/PT839196E/pt unknown
- 1996-07-18 DE DE69634726T patent/DE69634726T2/de not_active Expired - Lifetime
- 1996-07-18 ES ES96927237T patent/ES2242966T3/es not_active Expired - Lifetime
- 1996-07-18 AU AU67123/96A patent/AU727480B2/en not_active Ceased
- 1996-07-18 DK DK96927237T patent/DK0839196T3/da active
2007
- 2007-11-21 JP JP2007301924A patent/JP4319686B2/ja not_active Expired - Fee Related
2009
- 2009-04-02 JP JP2009090326A patent/JP2009197000A/ja active Pending

Also Published As

Publication number	Publication date
CA2227220A1 (en)	1997-02-06
JP2009197000A (ja)	2009-09-03
EP1591529A2 (en)	2005-11-02
PT839196E (pt)	2005-09-30
AU727480B2 (en)	2000-12-14
EP1591529A3 (en)	2005-11-09
WO1997004097A2 (en)	1997-02-06
EP0839196B1 (en)	2005-05-11
ATE295414T1 (de)	2005-05-15
ES2242966T3 (es)	2005-11-16
MX9800507A (es)	1998-05-31
DE69634726D1 (de)	2005-06-16
JP2008131942A (ja)	2008-06-12
JPH11510045A (ja)	1999-09-07
DE69634726T2 (de)	2006-05-04
WO1997004097A3 (en)	1997-09-12
JP4319686B2 (ja)	2009-08-26
EP0839196A2 (en)	1998-05-06
AU6712396A (en)	1997-02-18

Publication	Publication Date	Title
DK0839196T3 (da)	2005-09-12	Humant CTLA-8 og anvendelser af CTLA-8-relaterede proteiner
NO20074516L (no)	2000-07-20	Pattedyrcytokinlignende polypeptid-1
ATE536406T1 (de)	2011-12-15	Neuartiger zytokin-zcytor17-ligand
DK35593A (da)	1993-03-26	Polypeptid kodet af lav-dna-sekvens
DK150992A (da)	1992-12-17	Fremgangsmaade til fremstilling af et polypeptidfragment af faktor viii:c, dna-sekvens og ekstrachromosomalt element indeholdende en saadan dna-sekvens, som koder herfor
ATE64619T1 (de)	1991-07-15	Menschliches apolipoprotein a1 sowie dessen variante, exprimiert in escherichia coli.
ATE378408T1 (de)	2007-11-15	Transformierender wachstumsfaktor beta-9 (ztgfss9) aus säugetieren
DK1908772T3 (da)	2012-03-19	Polypeptider og polynucleinsyrer af phorphorymonas gingivalis
DE59810198D1 (de)	2003-12-24	Myc-bindende Zinkfinger-Proteine, ihre Herstellung und ihre Verwendung
DE60228136D1 (de)	2008-09-18	Cytokin-proteinfamilie
DK0728208T3 (da)	2003-07-21	Tomat-xyloglucan-endo-transglycosylase
CY1111763T1 (el)	2015-10-07	ΑΝΤΙΣΩΜΑΤΑ ΕΝΑΝΤΙΟΝ ΤΗΣ ΠΡΩΤΕΪΝΗΣ p51
DK0580672T3 (da)	1997-07-07	Syntetisk CDw52-(CAMPATH-1)-peptidantigen
DE59109235D1 (de)	2002-05-29	Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung
ATE432985T1 (de)	2009-06-15	Polypeptide mit aktivität der stimulierung von neutrophilen